2-(1-金刚烷基)-4-溴苯酚 | 104224-68-2

• 物质功能分类: 医药中间体 - 原料药中间体
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-(1-金刚烷基)-4-溴苯酚
• 中文别名: 2-金刚烷-4-溴苯酚；2-(1-金刚烷基)-4-溴苯酚 (阿达帕林)
• 英文名称: 2-(1-adamantyl)-4-bromophenol
• 英文别名: 2-adamantan-1-yl-4-bromophenol；2-(1-adamantanyl)-4-bromophenol
• CAS: 104224-68-2
• 化学式: C₁₆H₁₉BrO
• mdl: MFCD00169077
• 分子量: 307.23
• InChiKey: NYJXKHIVLGWPCF-UHFFFAOYSA-N

物化性质

• 熔点：
  137-141
• 沸点：
  392.0±35.0 °C(Predicted)
• 密度：
  1.442±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5.7
• 重原子数：
  18
• 可旋转键数：
  1
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.625
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2908199090
• 储存条件：
  室温

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Adamantyl-4-bromophenol
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Adamantyl-4-bromophenol
CAS number: 104224-68-2

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C16H19BrO
Molecular weight: 307.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

应用
2-(1-金刚烷基)-4-溴苯酚可作为医药合成中间体。可通过4-溴苯酚为原料进行制备，用于生成3-(1-金刚烷基)-4-苄氧基溴。

制备
方法1：将4-溴苯酚（0.346g，0.002mol）、1-金刚烷醇（0.152g，0.001mol）和1-溴金刚烷（0.022g，0.0001mol）（摩尔比为2：1：0.1）混合，在60℃下加热3小时。冷却后使用2% NaOH溶液处理以除去过量的4-溴苯酚。产物从异辛烷中重结晶，得到0.255g产品（产率83%），熔点为148-149℃。

反应信息

• 作为反应物：
  描述：

  2-(1-金刚烷基)-4-溴苯酚 在 bis-triphenylphosphine-palladium(II) chloride 、 potassium carbonate 、 magnesium 、 sodium hydroxide 、 zinc(II) chloride 作用下， 以 四氢呋喃 、 甲醇 、 丙酮 为溶剂， 反应 17.75h， 生成 阿达帕林
  参考文献：
  名称：

  6 [3-（1-金刚烷基）-4-甲氧基苯基] -2-萘甲酸的新合成及金刚烷基对萘类维生素A DNA结合的影响

  摘要：

  6 [3-（1-金刚烷基）-4-甲氧苯基] -2-萘甲酸（Adapalene®），合成的类视黄醇芳香特异于RARβ和RAR γ受体，已经制备利用的Pd / C介导的铃木6之间的耦合-溴-2-萘甲酸和4-甲氧基苯基硼酸，然后在形成的6-（4-甲氧基苯基）-2-萘甲酸的3位引入金刚烷基。在生理条件下，通过紫外-可见光谱研究了6-（4-甲氧基苯基）-2-萘甲酸/乙酯和3-金刚烷基类似物与DNA的相互作用。计算的结合常数K配体–DNA在1.1×10 4  M -1和1.1×10 5  M -1之间，较高的值对应于金刚烷化化合物的值。分子模型研究强调，阿达帕林及其衍生物与DNA的插入结合主要通过与金刚烷基存在有关的疏水相互作用来稳定。

  DOI：

  10.1016/j.bioorg.2011.07.003
• 作为产物：
  描述：

  4-溴苯酚 、 1-金刚烷醇 在 硫酸 、 溶剂黄146 作用下， 反应 48.0h， 以100%的产率得到2-(1-金刚烷基)-4-溴苯酚
  参考文献：
  名称：

  6 [3-（1-金刚烷基）-4-甲氧基苯基] -2-萘甲酸的新合成及金刚烷基对萘类维生素A DNA结合的影响

  摘要：

  6 [3-（1-金刚烷基）-4-甲氧苯基] -2-萘甲酸（Adapalene®），合成的类视黄醇芳香特异于RARβ和RAR γ受体，已经制备利用的Pd / C介导的铃木6之间的耦合-溴-2-萘甲酸和4-甲氧基苯基硼酸，然后在形成的6-（4-甲氧基苯基）-2-萘甲酸的3位引入金刚烷基。在生理条件下，通过紫外-可见光谱研究了6-（4-甲氧基苯基）-2-萘甲酸/乙酯和3-金刚烷基类似物与DNA的相互作用。计算的结合常数K配体–DNA在1.1×10 4  M -1和1.1×10 5  M -1之间，较高的值对应于金刚烷化化合物的值。分子模型研究强调，阿达帕林及其衍生物与DNA的插入结合主要通过与金刚烷基存在有关的疏水相互作用来稳定。

  DOI：

  10.1016/j.bioorg.2011.07.003

文献信息

• Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
  申请人：——

  公开号：US20020143182A1

  公开（公告）日：2002-10-03

  The invention relates to certain heterocyclic compounds useful for the treatment of cancer and other diseases, having the Formula (I): 1 wherein: (a) m is an integer 0 or 1; (b) R 12 is an alkyl, a substituted alkyl, a cycloalkyl, a substituted cycloalkyl, a heterocyclic, a substituted heterocyclic, a heteroaryl, a substituted heteroaryl, an aryl or a substituted aryl residue; (c) Ar 3 is an aryl, a substituted aryl, a heteroaryl or a substituted heteroaryl residue; (d) Ar 4 is an aryl, a substituted aryl, a heteroaryl or a substituted heteroaryl residue; (e) R 5 is hydrogen, hydroxy, alkyl or substituted alkyl; (f) - - - - - represents a bond present or absent; and (g) W, X, Y and Z are independently or together C(O)—, C(S), S, O, or NH; or a pharmaceutically acceptable salt thereof.

  该发明涉及某些对治疗癌症和其他疾病有用的杂环化合物，其具有以下式（I）： 1 其中： (a) m是整数0或1； (b) R12是烷基，取代烷基，环烷基，取代环烷基，杂环基，取代杂环基，杂芳基，取代杂芳基，芳基或取代芳基残基； (c) Ar3是芳基，取代芳基，杂芳基或取代杂芳基残基； (d) Ar4是芳基，取代芳基，杂芳基或取代杂芳基残基； (e) R5是氢，羟基，烷基或取代烷基； (f) - - - - - 代表存在或不存在的键；以及 (g) W、X、Y和Z独立或一起是C(O)、C(S)、S、O或NH；或其药学上可接受的盐。
• [EN] S1P RECEPTORS MODULATORS AND THEIR USE THEREOF<br/>[FR] MODULATEURS DES RÉCEPTEURS S1P ET LEUR UTILISATION
  申请人：AKAAL PHARMA PTY LTD

  公开号：WO2010043000A1

  公开（公告）日：2010-04-22

  The invention relates to novel compounds that have S1P receptor modulating activity. Further, the invention relates to a pharmaceutical comprising at least one compound of the invention for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression, for example, autoimmune response. A further aspect of the invention relates to the use of a pharmaceutical comprising at least one compound of the invention for the manufacture of a medicament for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression such as autoimmune response.

  这项发明涉及具有S1P受体调节活性的新化合物。此外，该发明涉及包括本发明中至少一种化合物的药物，用于治疗由不当的S1P受体调节活性或表达引起或相关的疾病和/或病况，例如自身免疫反应。该发明的另一个方面涉及使用包括本发明中至少一种化合物的药物制造药物，用于治疗由不当的S1P受体调节活性或表达引起或相关的疾病和/或病况，如自身免疫反应。
• Anti-cancer agents and uses thereof
  申请人：Kelly Martha

  公开号：US20060270686A1

  公开（公告）日：2006-11-30

  The present invention is in the area of novel compounds and salts thereof, their syntheses, and their use as anti-cancer agents. The compounds include compounds of Formula I: and solvates, hydrates and pharmaceutically-acceptable salts thereof, wherein A 1 is N or CR 1 ; A 3 is N or CR 3 ; A 5 is N or CR 5 ; R 1 , R 3 —R 6 and L are defined in the specification; n is 0 or 1; and X is an optionally-substituted aryl group having 6-10 carbons in the ring portion, an optionally-substituted 6-membered heteroaryl group having 1-3 nitrogen atoms in the ring portion, an optionally-substituted 5-membered heteroaryl group having 0-4 nitrogen atoms in the ring portion and optionally having 1 sulfur atom or 1 oxygen atom in the ring portion, or an optionally-substituted heteroaryl group in which a 6-membered ring is fused either to a 5-membered ring or to a 6-membered ring, wherein in each case 1, 2, 3 or 4 ring atoms are heteroatoms independently selected from nitrogen, oxygen and sulfur. They are effective against a broad range of cancers, especially leukemia, non-small cell lung and colon.

  本发明涉及新化合物及其盐，它们的合成以及它们作为抗癌剂的用途。这些化合物包括式I的化合物： 和其溶剂化物、水合物和药用可接受盐，其中A 1 为N或CR 1 ；A 3 为N或CR 3 ；A 5 为N或CR 5 ；R 1 ，R 3 —R 6 和L在说明书中有定义；n为0或1；X为在环部分具有6-10个碳的可选择取代芳基，在环部分具有1-3个氮原子的可选择取代的6元杂芳基，在环部分具有0-4个氮原子且可选择具有1个硫原子或1个氧原子的可选择取代的5元杂芳基，或者在其中6元环与5元环或6元环融合的可选择取代的杂芳基，其中在每种情况下1、2、3或4个环原子是从氮、氧和硫中独立选择的杂原子。它们对广泛范围的癌症，特别是白血病、非小细胞肺癌和结肠癌有效。
• NOVEL COMPOUNDS, SYNTHESIS METHOD THEREOF AND USE OF SAME IN MEDICINE AND IN COSMETICS
  申请人：GALDERMA RESEARCH & DEVELOPMENT

  公开号：US20170342040A1

  公开（公告）日：2017-11-30

  Novel compounds, synthesis methods and use of the same in medicine and in cosmetics are disclosed. Also disclosed, are novel compounds and ligands that modulate RARs.

  小说化合物、合成方法以及在医学和化妆品中使用这些化合物的方法被披露。还披露了调节RARs的新化合物和配体。
• [EN] PHENOL DERIVATIVES FOR USE AS ANTIMICROBIAL, ANTIBACTERIAL, BACTERICIDE<br/>[FR] DÉRIVÉS DE PHÉNOL DESTINÉS À ÊTRE UTILISÉS COMME ANTIMICROBIENS, ANTIBACTÉRIENS, ET BACTÉRICIDES
  申请人：SPECIAL PRODUCTS LINE S P A

  公开号：WO2020178053A1

  公开（公告）日：2020-09-10

  Phenol derivatives of general formula (I) and (II), wherein meanings of the substituents are indicated in the description, their pharmaceutically acceptable salts, together with the processes for their preparation, their use as antimicrobial, antibacterial, bactericide agents and the corresponding pharmaceutical compositions are disclosed.

  通式（I）和（II）的酚衍生物，其中取代基的含义在描述中指明，它们的药用盐，以及它们的制备方法，它们作为抗微生物、抗菌、杀菌剂的用途以及相应的药物组成物被披露。